1. Profile of p53 expression in bladder and oral tumours
- Author
-
Nagy A. Habib, H. Cannell, A.M.E. Nouri, A.A.N.P.M Dabare, B. Dagini, and C.G Fowler
- Subjects
Cisplatin ,Cancer Research ,Pathology ,medicine.medical_specialty ,Genetic transfer ,Transfection ,Biology ,medicine.disease ,Transitional cell carcinoma ,Oncology ,Cell culture ,Epidermal growth factor ,Apoptosis ,Gene expression ,Cancer research ,medicine ,medicine.drug - Abstract
In this investigation the profile of p53 and epidermal growth factor receptor (EGFR) expression in tumour tissue biopsies of transitional cell carcinoma of bladder (TCC) and of oral-pharyngeal carcinoma (OP) were compared using an immunocytochemical staining method. In addition, various techniques including sodium dodecyl sulphate-polyacrylamide gel elecrophoresis (SDS-PAGE), colorimetric assay and gene transfection were used to investigate the influence of p53 on the behaviour of human tumour cell lines in vitro. The results showed that: (a) p53 was detectable in more than 45% of cases in both tumour types, although the profile and intensity of expression differed. (b) Concomitant strong expression of EGFR and p53 for TCC and OP was 21% and 38% (P>0.05%), respectively. (c) Treatment of tumour cells by either gamma radiation or by cisplatin resulted in the induction of p53 independent of the origin of the tumour. (d) Susceptibility of two cell lines, one with and one without constitutive expression of p53 showed that the expressing cells were more sensitive to gamma radiation (the percentage inhibition at 250 cGy was 57% versus −15%, P
- Published
- 2000
- Full Text
- View/download PDF